Home Cart Sign in  
Chemical Structure| 494-38-2 Chemical Structure| 494-38-2
Chemical Structure| 494-38-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Synonyms: Acridine Orange; NSC 194350; C.I. 46005B

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Liu, Yichen ; Kim, Gaeun ; Zhu, Runyao ; Jeon, Hyunsu ; Wang, Yichun ;

Abstract: Tumor hypoxia and poor penetration of therapeutics across tumor-microenvironment barriers remain major obstacles to effective cancer therapy, including photodynamic therapy (PDT). Here we introduce a nanochirality-programmed assembly (L-Chi-GAIN) in which nanochirality drives site-selective assembly that activates oxygen-independent Type-I reactive oxygen species (ROS) generation and reduces hyaluronan-mediated matrix adhesion, thereby permitting deep intratumoral therapy. Glycosylation imparts structural chirality to graphene quantum dots (GQDs), directing site-selective assembly of indocyanine green (ICG) that turns on photoinduced electron transfer (PET), producing a 64-fold increase in ROS relative to free ICG. Nanochirality also modulates assembly–extracellular matrix (ECM) interactions. L-GQDs show a less favorable hyaluronan binding free energy (ΔGbind), thus accelerating interstitial transport and resulting in ∼21-fold deeper tumor penetration by L-Chi-GAIN than conventional nanocarriers. Under near-infrared irradiation, L-Chi-GAIN elicits strong oxidative stress and triggers Gasdermin-D (GSDMD)-dependent pyroptosis, leading to significant suppression of tumor growth. This work offers a nanochirality-guided design strategy for PDT in deep tumors by coupling site-selective assembly with stereoselective navigation of the ECM.

Keywords: Graphene quantum dot ; Solid tumor ; Type-I reactive oxygen species ; Chirality ; Extracellular matrix

Purchased from AmBeed: ; ; ; ;

Alternative Products

Product Details of Acridine Orange base

CAS No. :494-38-2
Formula : C17H19N3
M.W : 265.35
SMILES Code : CN(C)C1=CC=C2C(N=C3C=C(N(C)C)C=CC3=C2)=C1
Synonyms :
Acridine Orange; NSC 194350; C.I. 46005B
MDL No. :MFCD00005029
InChI Key :DPKHZNPWBDQZCN-UHFFFAOYSA-N
Pubchem ID :62344

Safety of Acridine Orange base

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338
 

Historical Records

Categories